Delcath Completes Enrollment in its United States Registration Pivotal Trial (FOCUS) Investigating Melphalan/HDS in the Treatment of Patients with Unresectable Hepatic-Dominant Ocular Melanoma

    NEXT STORY
    Editas Medicine and Sandhill Therapeutics, Inc. Announce Collaboration to Develop Engineered Cell Medicines to Treat Cancer
    PREV STORY
    Resverlogix Confirms a Significant Corporate Advancement Establishing Apabetalone as a Potential Blockbuster Combination Drug in High-risk Diabetes Patients with CVD
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Albireo Announces Elobixibat Data from Japan to be Presented at DDW 2017

    BOSTON, April 27, 2017 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan ...

    author_avatar
    NASDAQ Market News

    Vir Biotechnology Publishes New Research Characterizing Variation in the SARS-CoV-2 Spike Protein and Virulence of a Prevalent Immune Evasion Variant, N439K

    author_avatar
    NASDAQ Market News

    Outlook on the Worldwide Gene Therapy Industry to 2024 – Insights & Forecast with Potential Impact of COVID-19

    author_avatar
    NASDAQ Market News